Unrecognized Hypo- and Hyperglycemia in Well-Controlled Patients with Type 2 Diabetes Mellitus: The Results of Continuous Glucose Monitoring
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The aim of this study was to determine the prevalence and extent of glycemic excursions (hypo- and hyperglycemic) in elderly patients with well-controlled type 2 diabetes using a Continuous Glucose Monitor System (CGMS) (Medtronic MiniMed). Elderly patients (>65 years old) with type 2 diabetes were recruited if their glycosylated hemoglobin (HbA1c) was <7.5% and if their oral hypoglycemic therapy included a sulfonylurea. Patients were asked to undergo two consecutive 72-h periods of continuous glucose monitoring at baseline and then again at 1 month (total 288 h). Patients were asked to record four self-monitored capillary blood glucose levels each day for calibration of the monitor and also to record meal times, exercise, and symptoms of hypoglycemia. The number of hyperglycemic (>144 mg/dL), hypoglycemic (<50 mg/dL), and borderline-hypoglycemic (50-65 mg/dL) events were determined (an event was defined as a glucose value that persisted for at least 15 min with or without symptoms). Twenty-five patients (21 men, four women) 73.9 +/- 4.4 years old with an HbA1c of 6.2 +/- 0.8% were each monitored for an average of 187.57 h. The mean glucose values were: fasting, 139 +/- 40 mg/dL; 2 h post-breakfast, 167 +/- 58 mg/dL; 2 h post-lunch, 157 +/- 53 mg/dL; and 2 h post-dinner, 149 +/- 49 mg/dL. Twenty patients (80%) experienced a total of 103 hypoglycemic events, and 14 of these patients experienced 54 events where the glucose levels were </=40 mg/dL. Twenty-four patients (96%) experienced borderline-hypoglycemia (n = 229 events). Patients experienced a mean of 0.62 +/- 0.72 episodes of hypoglycemia (interstitial glucose <50 mg/dL) per day (four to five episodes overall), 0.35 +/- 0.6 episodes per day where the interstitial glucose was </=40 mg/dL (two to three episodes overall), and 1.37 +/- 1.22 episodes of borderline-hypoglycemia (nine to 10 episodes overall). Each episode of hypoglycemia persisted for 78 +/- 73 min, and borderline-hypoglycemia for 45 +/- 11 min. Patients were hypoglycemic 3.3% of the time and borderline-hypoglycemic 3.7% of the time. No episode of hypoglycemia was recorded by any patient in his or her daily diary. High postprandial glucose values (>144 mg/dL 2 h postprandial) were recorded after 57% of all meals (breakfast 60%, lunch 57.5%, dinner 55.2%). The CGMS was generally well tolerated, but 52% of patients could not be studied for the full 12 days of monitoring. Thus hypoglycemia and excessive postprandial glycemic excursions are common in well-controlled patients with type 2 diabetes treated with a sulfonylurea with or without metformin. The CGMS is a useful research and clinical tool to assess glycemia in patients with type 2 diabetes but is not tolerated by all subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In patients with diabetes and an ICD, there is an increased risk of death in those who have appropriate therapy compared to those who do not.659”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [659]
In the citing paper
“In contrast, patients with diabetes may have a lower risk of inappropriate therapy or ICD shock, since they may be more sedentary with consequently less frequent exercise-induced sinus tachycardia and also lower incidence of lead fracture.600,658,659”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [659]
In the citing paper
“Readings of Ͻ2.2 mmol/l (Ͻ40 mg/dl) for at least 15 min were recorded in 56% of subjects and none were perceived (85).”
From Hypoglycemia in Type 2 Diabetes (2005) · cites this paper as [85]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The Prevention or Delay of Type 2 Diabetes
American Diabetes Association, & National Institute of Diabetes, D. A. K. D. (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s62 · Cited by 519
The Prevention or Delay of Type 2 Diabetes
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.4.742 · Cited by 489
Limitations of Conventional Methods of Self-Monitoring of Blood Glucose
Boland, E., Monsod, T., Delucia, M., Brandt, C. A., Fernando, S., & Tamborlane, W. V. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1858 · Cited by 423
The MiniMed Continuous Glucose Monitoring System
Mastrototaro, J. J. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050214078 · Cited by 393
Size at birth, maternal weight, and Type 2 diabetes in South India
Fall, C. H. D., Stein, C. E., Kumaran, K., Cox, V., Osmond, C., Barker, D. J. P., & Hales, C. N. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199803)15:3<220::aid-dia544>3.0.co;2-o · Cited by 266
A Pilot Study of the Continuous Glucose Monitoring System
Kaufman, F. R., Gibson, L. C., Halvorson, M., Carpenter, S., Fisher, L. K., & Pitukcheewanont, P. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2030 · Cited by 224
Tuttle, K. R., Bruton, J. L., Perusek, M. C., Lancaster, J. L., Kopp, D. T., & DeFronzo, R. A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106063242304 · Cited by 217 · cited 1×
“7 For example, available evidence suggests that acute hyperglycemia can result in increased glomerular filtration rate, 11 mesangial collagen hyperproduction, 12 increased retinal blood flow, 13 and decreased motor and sensory nerve conduction velocity.”
Ceriello, A. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199803)15:3<188::aid-dia545>3.0.co;2-v · Cited by 186 · cited 1×
“7 For example, available evidence suggests that acute hyperglycemia can result in increased glomerular filtration rate, 11 mesangial collagen hyperproduction, 12 increased retinal blood flow, 13 and decreased motor and sensory nerve conduction velocity.”
Research works printed but not linked: 3
- American Diabetes Association, 2002, Diabetes Care, 25, S97, 10.2337/diacare.25.4.742 · DOI · Paper page
- 10.1002/(SICI)1096-9136(199803)15:3<188::AID-DIA545>3.3.CO;2-M · doi:10.1002/(sici)1096-9136(199803)15:3<188::aid-dia545>3.3.co;2-m
- Takeuchi A, 1995, Am J Physiol, 268, F13
Cited by
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Hypoglycemia in Type 2 Diabetes
Zammitt, N. N., & Frier, B. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2948 · Cited by 435
Loh, R., Stamatakis, E., Folkerts, D., Allgrove, J. E., & Moir, H. J. (2020) · Sports Medicine · doi:10.1007/s40279-019-01183-w · Cited by 326
“Post-prandial and nocturnal hyperglycaemic excursions might be an early and undetected aspect of an insulin-resistant state [101].”
BackgroundCarbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes
Brazeau, A. S., Mircescu, H., Desjardins, K., Leroux, C., Strychar, I., Ekoé, J. M., & Rabasa-Lhoret, R. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.024 · Cited by 265
“9 mmol/L, were computed [15].”
Metadata
- Authors
- Hay, L. C., Wilmshurst, E. G., & Fulcher, G.
- Affiliations
- Royal North Shore Hospital (AU)
- ORCID
- Fulcher, Gregory
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2003-02
- Volume
- 5
- Issue
- 1
- Pages
- 19-26
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2087557966
- Cited by
- 143
- References
- 22
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 10 · 2018: 7 · 2017: 8 · 2016: 6 · 2015: 7 · 2014: 9 · 2013: 10 · 2012: 7
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
- Locations
- Diabetes Technology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novartis Australia
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 2 diabetes, hypoglycemia, hyperglycemia, glycemic excursions, continuous glucose monitoring, elderly patients, sulfonylurea therapy, glycemic variability, glycemic control, HbA1c, self-monitoring of blood glucose, nocturnal hypoglycemia
- MeSH terms
- Aged, Blood Glucose, Blood Pressure, Circadian Rhythm, Diabetes Mellitus, Type 2, Eating, Female, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Male, Sulfonylurea Compounds, Blood Glucose Self-Monitoring, Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unrecognized Hypo- and Hyperglycemia in Well-Controlled Patients with Type 2 Diabetes Mellitus: The Results of Continuous Glucose Monitoring. https://app.cochat.ai/papers/10.1089/152091503763816427
- The paper
- Hay, L. C., Wilmshurst, E. G., & Fulcher, G. (2003). Unrecognized Hypo- and Hyperglycemia in Well-Controlled Patients with Type 2 Diabetes Mellitus: The Results of Continuous Glucose Monitoring. Diabetes Technology & Therapeutics. https://doi.org/10.1089/152091503763816427
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.